NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Waaree Energies Reports Robust Revenue in 4QFY26, Misses Estimates on EBITDA Margin

Waaree Energies (WEL) has reported a robust revenue of INR84.8 billion in 4QFY26, surpassing the research firm Motilal Oswal's estimates by 26%. However, the company's EBITDA margin came in 7% below expectations, due to a lower-than-expected margin of 19%. This decline was attributed to several factors, including elevated silver and copper prices, increased freight costs, a weaker overseas revenue mix, and reliance on externally procured DCR cells to fulfill certain module orders.

As a result, the company's earnings before interest, taxes, depreciation, and amortization (EBITDA) came in at INR10.6 billion, missing estimates by 6%. Despite this, module production increased by 19% quarter-over-quarter, while cell production declined by 12% due to the transition of three cell lines to G12R during the quarter.

Motilal Oswal's Research Report Highlights

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Metric4QFY26 Actual4QFY26 Estimated
RevenueINR84.8 billionINR67.1 billion
EBITDA Margin19%20.7%
APATINR10.6 billionINR11.2 billion

The research firm has derived the valuation of WEL through a sum-of-the-parts (SoTP) methodology, resulting in a target price of INR3,725 per share.

Investor Takeaway

Investors should be cautious about Waaree Energies due to its lower-than-expected EBITDA margin and reliance on externally procured DCR cells.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.